Products for Research Use Only

Feruloylputrescine

CAT: 0804-HY-W327449-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W327449-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Feruloylputrescine is an oral active phenolamide found in citrus plants and formed through the decarboxylation of L-Arginine. Feruloylputrescine inhibits monooxygenase (cntA) and reductase (cntB) and trimethylamine production. Feruloylputrescine can be used for cardiovascular diseases research[1].
CAS Number
501-13-3
UNSPSC
12352005
Hazard Statement
H301+H311+H331, H315, H319, H335, H373
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Metabolic Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/feruloylputrescine.html
Purity
99.34
Solubility
DMSO : 5 mg/mL (ultrasonic)
Smiles
COC1=C(O)C=CC(C=CC(NCCCCN)=O)=C1
Molecular Formula
C14H20N2O3
Molecular Weight
264.32
Precautions
H301+H311+H331, H315, H319, H335, H373
References & Citations
[1]Hana Lee, et al. Discovery of a Novel Bioactive Compound in Orange Peel Polar Fraction on the Inhibition of Trimethylamine and Trimethylamine N-Oxide through Metabolomics Approaches and In Vitro and In Vivo Assays: Feruloylputrescine Inhibits Trimethylamine via Suppressing cntA/B Enzyme. J Agric Food Chem. 2024 Apr 10;72 (14) :7870-7881. |[2]Nakase K, et al. Effects of pollen-extract components, diamines and derivatives of feruloylputrescine on isolated bladder and urethral smooth muscles of mice. Jpn J Pharmacol. 1990 Jun;53 (2) :157-64.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported